Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study (pages 217–228)
Andrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, Carmel M Hawley, Peta-Anne Paul-Brent, Sunil V Badve, Alan Cass, David W Johnson, Peter G Kerr, Trevor A Mori, Anish Scaria, Seong L Hooi, Meng L Ong, Ashley B Irish and on behalf of the FAVOURED Study Team
Article first published online: 28 JAN 2016 | DOI: 10.1111/nep.12573
Summary at a Glance
The Fish oils and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial investigated whether 3 months of omega-3 polyunsaturated fatty acids, either alone or in combination with aspirin, would effectively reduce primary access failure of de novo arteriovenous fistulae. This report presents the baseline characteristics of all study participants, and examines whether study protocol amendments successfully increased recruitment of a broader and more representative haemodialysis cohort, including patients already receiving aspirin, and compares Malaysian participants with those from Australia, New Zealand and the United Kingdom. The FAVOURED study participants were on average younger and had less ischaemic heart disease than in contemporary national registry reports, and these differences were reduced as a consequence of including patients already receiving aspirin.